SOLICITATION NOTICE
66 -- Manufacturing an In Vitro Component for Evaluating Generic and New Animal Formulations that are not Systemically Absorbed
- Notice Date
- 1/13/2020 10:56:27 AM
- Notice Type
- Solicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- FDA OFFICE OF ACQ GRANT SVCS ROCKVILLE MD 20857 USA
- ZIP Code
- 20857
- Solicitation Number
- FDA-SOL-NOI-1222321
- Response Due
- 1/20/2020 7:00:00 AM
- Archive Date
- 01/20/2020
- Point of Contact
- Sarah Hussain, Phone: 240-402-3796
- E-Mail Address
-
Sarah.Hussain@fda.hhs.gov
(Sarah.Hussain@fda.hhs.gov)
- Description
- The U.S. Food & Drug Administration (FDA) intends to issue a Sole Source follow-on award to the University of Maryland for continuing existing clinical studies.� The Government intends to issue a sole source award in accordance with FAR 6.302-1, only one responsible source and no other will satisfy the agency requirements for the above stated service. The scope of the existing work is to continue ongoing stability studies to confirm the stability of tablets that shall be provided to the FDA for an in vivo BE study and to present the FDA with tablets that are packaged in a manner that will enhance the stability and integrity of the individual tablets.
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/d26e7712586f498481bbef035c4785a4/view)
- Record
- SN05533437-F 20200115/200113230302 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |